Role of Testosterone Signaling in Microglia: A Potential Role for Sex-Related Differences in Alzheimer's Disease

Haiyan Du1, Akiko Mizokami2, Junjun Ni3

  • 1Department of Cell Biology, Aging Science, and Pharmacology, Division of Oral Biological Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Insights

Testosterone enhances amyloid-beta clearance in microglia by promoting autophagy, potentially explaining why men have lower Alzheimer's disease prevalence. This process involves suppressing ERK and mTOR pathways via GPRC6A.

Area of Science:

  • Neuroscience
  • Immunology
  • Endocrinology

Background:

  • Alzheimer's disease (AD) affects women more than men, with unclear mechanisms.
  • Microglia clear amyloid-beta (Aβ) via autophagy, a cellular degradation process.
  • Testosterone signaling, mediated by GPRC6A in microglia, is a potential factor.

Purpose of the Study:

  • To investigate testosterone's role in modulating Aβ-induced autophagy in microglia.
  • To elucidate the molecular pathways involved in testosterone's effects on microglial Aβ clearance.

Main Methods:

  • In vitro studies using mouse microglial MG6 cells treated with Aβ and testosterone.
  • Gene knockdown experiments using shRNA targeting GPRC6A.
  • In vivo studies using male 5xFAD AD model mice, including orchiectomy and testosterone supplementation.
  • Analysis of Aβ and p62 aggregates in human AD brain samples.

Main Results:

  • Testosterone promotes Aβ-induced autophagy in MG6 cells by suppressing ERK phosphorylation and mTOR activation.
  • GPRC6A mediates testosterone's effect on autophagy; knockdown abrogates the effect.
  • In 5xFAD mice, orchiectomy reduces Aβ clearance, while testosterone restores it.
  • Men with AD show lower Aβ accumulation and less p62 colocalization, suggesting higher autophagic activity.

Conclusions:

  • Testosterone enhances autophagy-mediated Aβ clearance in microglia.
  • This mechanism may contribute to the lower prevalence of Alzheimer's disease in men.
  • GPRC6A is a key mediator of testosterone's neuroprotective effects in AD.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
412
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
367
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
142